TB-500 (10 mg Vial)
Dosing & reconstitution protocol
Quick Reference
Overview
TB-500 is a synthetic peptide fragment corresponding to the active region of thymosin beta-4. This protocol uses 3.0 mL reconstitution of the 10 mg vial for ~3.33 mg/mL concentration, keeping per-injection units in a comfortable range for accurate measurement.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 500 mcg | 15 units | 0.15 mL |
| Weeks 3–4 | 600 mcg | 18 units | 0.18 mL |
| Weeks 5–8 | 750 mcg | 23 units | 0.23 mL |
| Weeks 9–12 | 1000 mcg | 30 units | 0.30 mL |
Reconstitution Instructions
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 28 days with bacteriostatic water preservative.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓Peptide Vials (TB-500, 10 mg): 4 vials
- ✓Insulin Syringes (U-100): 56 syringes
- ✓Bacteriostatic Water (10 mL): 2 bottles (12 mL needed)
- ✓Alcohol Swabs: 2 × 100-count boxes
Dosing Protocol
Schedule
Inject once daily subcutaneously. Total weekly dose averages ~5 mg. Gradual titration from 500 mcg.
Cycle Structure
8–12 weeks; optional extension to 16 weeks. Follow with a 2–4 week break before repeating.
Timing
Any consistent time daily; rotate injection sites systematically.
Storage & Handling
- ✓Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions.
- ✓Reconstituted: Refrigerate at 2–8 °C; do not freeze reconstituted solution.
- ✓Allow vials to reach room temperature before opening to reduce condensation.
- ✓Use reconstituted vials within 28 days with bacteriostatic water preservative.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Use new sterile insulin syringes for each injection; dispose in a sharps container.
- ✓Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- ✓Inject slowly; wait a few seconds before withdrawing the needle.
- ✓TB-500 is banned by WADA for athletic use and is not FDA-approved for human administration.